EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Advances In Pharma Business Management And Research Lars Schweizer Theodor Dingermann Otto Quintus Russe Christian Jansen

Name: Advances In Pharma Business Management And Research Lars Schweizer Theodor Dingermann Otto Quintus Russe Christian Jansen
SKU: BELL-59046578
Price: 31.00 USD
Availability: InStock
Rating: 5 (100 reviews)

SKU: BELL-59046578

$ 31.00 ~~$ 45.00~~ (-31%)

5.0

100 reviews

Advances In Pharma Business Management And Research Lars Schweizer Theodor Dingermann Otto Quintus Russe Christian Jansen instant download after payment.

Publisher: Springer

File Extension: PDF

File size: 1.72 MB

Author: Lars Schweizer & Theodor Dingermann & Otto Quintus Russe & Christian Jansen

Language: English

Year: 2020

Product desciption

Advances In Pharma Business Management And Research Lars Schweizer Theodor Dingermann Otto Quintus Russe Christian Jansen by Lars Schweizer & Theodor Dingermann & Otto Quintus Russe & Christian Jansen instant download after payment.

This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'.